Annual Drug Patent Expirations for REZZAYO
Rezzayo is a drug marketed by Cidara Theraps and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has fifty-seven patent family members in twenty-three countries.
The generic ingredient in REZZAYO is rezafungin acetate. One supplier is listed for this compound. Additional details are available on the rezafungin acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
